AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rai, A. T.
Right arrow Articles by Hogg, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rai, A. T.
Right arrow Articles by Hogg, J. P.

ARTICLE

Persistence of Gadolinium in CSF: A Diagnostic Pitfall in Patients with End-stage Renal Disease

Ansaar T. Raia and Jeffery P. Hogga

a From the Department of Radiology, West Virginia University, 2278 HSCS, Morgantown, WV 26506–9235.

Summary: Two dialysis-dependent patients with end-stage renal disease underwent brain and spine MR imaging a few days after having undergone gadolinium-enhanced imaging studies. Increased signal intensity in the subarachnoid space on T1-weighted and fluid-attenuated inversion recovery images was noted. Excretion of gadolinium into the CSF was proven in one case by mass spectrometry. Dialysis-dependent patients with end-stage renal disease and neurologic abnormalities often undergo contrast-enhanced MR imaging. Recognition that these patients may show increased signal intensity in the subarachnoid space because of gadolinium excretion into CSF may prevent diagnostic errors.




This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
K K THA, S TERAE, K KUDO, and K MIYASAKA
Differential diagnosis of hyperintense cerebrospinal fluid on fluid-attenuated inversion recovery images of the brain. Part I: pathological conditions
Br. J. Radiol., May 1, 2009; 82(977): 426 - 434.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
F.K. Hui and M. Mullins
Persistence of Gadolinium Contrast Enhancement in CSF: A Possible Harbinger of Gadolinium Neurotoxicity?
AJNR Am. J. Neuroradiol., January 1, 2009; 30(1): e1 - e1.
[Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
J.M. Morris and G.M. Miller
Increased Signal in the Subarachnoid Space on Fluid-Attenuated Inversion Recovery Imaging Associated with the Clearance Dynamics of Gadolinium Chelate: A Potential Diagnostic Pitfall
AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1964 - 1967.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
T. Hirai, Y. Ando, M. Yamura, M. Kitajima, Y. Hayashida, Y. Korogi, T. Yamashita, and Y. Yamashita
Transthyretin-Related Familial Amyloid Polyneuropathy: Evaluation of CSF Enhancement on Serial T1-Weighted and Fluid-Attenuated Inversion Recovery Images following Intravenous Contrast Administration
AJNR Am. J. Neuroradiol., September 1, 2005; 26(8): 2043 - 2048.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. V. Maramattom, E. M. Manno, E. F.M. Wijdicks, and E. P. Lindell
Gadolinium encephalopathy in a patient with renal failure
Neurology, April 12, 2005; 64(7): 1276 - 1278.
[Abstract] [Full Text] [PDF]